Chromium chloride inhibits TNFalpha and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose

Horm Metab Res. 2006 Jan;38(1):60-2. doi: 10.1055/s-2006-924981.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cells, Cultured
  • Chlorides / pharmacology*
  • Chromium Compounds / pharmacology*
  • Diabetic Angiopathies / diet therapy
  • Diabetic Angiopathies / metabolism
  • Dietary Supplements*
  • Dose-Response Relationship, Drug
  • Glucose / metabolism*
  • Glucose / pharmacology
  • Humans
  • Interleukin-6 / metabolism*
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / metabolism*
  • Myocardial Infarction / diet therapy
  • Myocardial Infarction / etiology
  • Myocardial Infarction / metabolism
  • Nails / metabolism
  • Risk Factors
  • Tumor Necrosis Factor-alpha / metabolism*
  • Vasculitis / diet therapy
  • Vasculitis / etiology
  • Vasculitis / metabolism

Substances

  • Chlorides
  • Chromium Compounds
  • IL6 protein, human
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • chromous chloride
  • Glucose